Figure 1

![Figure 1: Classification and risk factors for mild cognitive impairment (MCI), illustrating the clinical heterogeneity of MCI and factors that increase the risk of progression to dementia.]()

> Source: Carlo Tomino et al. "Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®." *Pharmaceuticals (Basel, Switzerland)*, 2021. PMID: [33915701](https://pubmed.ncbi.nlm.nih.gov/33915701/)

<figure>
  <img src="" alt="Classification and risk factors for mild cognitive impairment (MCI), illustrating the clinical heterogeneity of MCI and factors that increase the risk of progression to dementia." />
  <figcaption>Figure 1. Classification and risk factors for mild cognitive impairment (MCI), illustrating the clinical heterogeneity of MCI and factors that increase the risk of progression to dementia.<br>  Source: Carlo Tomino et al. "Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33915701/">33915701</a></figcaption>
</figure>